ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Pharmacy, Surgery, Conference News, Source Type: news
More News: Cancer | Cancer & Oncology | Conferences | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Urology & Nephrology